AURKB and acute myeloid leukemia: Previous studies indicated that P53 can be upregulated by the treatment of an Aurora B kinase inhibitor called AZD1152-HQPA in acute myelogenous leukemia cells, suggesting a functional connection between Aurora B and P53 [34].